OR WAIT null SECS
January 02, 2016
Parenteral packaging of the future will include more automated lines, ready-to-fill packaging formats, and supply-chain transparency.
December 02, 2015
Microorganism lethality requirements for process validation must always be balanced with the need to protect product integrity and patient safety.
November 19, 2015
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
November 02, 2015
Delamination of glass packaging is a source of particulates in parenteral drugs, but identifying the root cause allowed the design of an improved manufacturing process for glass vials.
Although shortages, quality, and regulatory challenges remain, improved technologies and new investments suggest that the worst may be over.
Miriam Beyer, European marketing manager, West Pharmaceutical Services, describes causes of recent parenteral drug shortages.
October 15, 2015
Scottish injectable-drug manufacturer Symbiosis Pharmaceutical Services plans to expand its sterile filling facility.
October 06, 2015
The challenge of achieving zero visible defects (i.e., particulates) in parenteral drugs will require a coordinated effort at all stages of the supply chain, particularly in the production and filling of primary containers.
October 02, 2015
Manufacturers of parenteral drugs face challenges to increase efficiency, control particulates, control extractables and leachables, and eliminate product/package interactions; new containers and packaging equipment offer increased options.
GEA’s Pony NS2006L is a self-contained, high-pressure laboratory and pilot plant homogenizer for product development of advanced fluid applications.